ONO
LIVE

Serial Number

79379120

Owner

ONO PHARMACEUTICAL CO., LTD.

Attorney

Perla M. Kuhn

Filing Date

Apr 3, 2023

Add to watchlist:

No watchlists yet
View on USPTO

ONO Trademark

Serial Number: 79379120 • Registration: 7464726

ONO is a trademark filed by ONO PHARMACEUTICAL CO., LTD. on April 3, 2023. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

ONO PHARMACEUTICAL CO., LTD.

1-5, Doshomachi 2-chome,

Entity Type: 03

Trademark Details

Filing Date

April 3, 2023

Registration Date

August 6, 2024

Published for Opposition

May 21, 2024

Goods & Services

Anti-cancer preparations; chemical preparations for sanitary purposes; chemical preparations for medicinal purposes for treating cardiovascular disorders, genitourinary disorders, gynecological diseases and obstetric diseases, cancer and its metastasis, eye disorders, neurologic disorders, psychiatric disorders, endocrine and metabolic disorders, allergic disorders, gastrointestinal disorders, immune diseases and autoimmune diseases, respiratory diseases, musculoskeletal and connective tissue disorders, infectious diseases, dermatologic disorders, hematological disorder, inflammatory diseases, ear, nose, dental and throat disorders, hepatic and biliary disorders, Alzheimer's disease, and diabetes and its complications; diagnostic preparations for medical purposes; medicated toiletry preparations; sanitary preparations for medical purposes; fungicides; sterilizing preparations; disinfectants for hygiene purposes; pharmaceutical preparations for the treatment and prevention of cardiovascular disorders, genitourinary disorders, gynecological diseases and obstetric diseases, cancer and its metastasis, eye disorders, neurologic disorders, psychiatric disorders, endocrine and metabolic disorders, allergic disorders, gastrointestinal disorders, immune diseases and autoimmune diseases, respiratory diseases, musculoskeletal and connective tissue disorders, infectious diseases, dermatologic disorders, hematological disorder, inflammatory diseases, ear, nose, dental and throat disorders, hepatic and biliary disorders, Alzheimer's disease, and diabetes and its complications; pharmaceutical preparations for cancer supportive care; general and topical anesthetic, sedative and analgesic drugs; vaccines

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Mar 8, 2025 OPNX
FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 22, 2025 FINO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 20, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Feb 20, 2025 OPNR
FINAL DISPOSITION NOTICE SENT TO IB
Jan 31, 2025 FICS
FINAL DISPOSITION PROCESSED
Jan 31, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 7, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 6, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 6, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 21, 2024 NPUB
PUBLISHED FOR OPPOSITION
May 21, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 1, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 15, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 15, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 15, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 15, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 15, 2024 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 10, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 10, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 10, 2024 TROA
REFUSAL PROCESSED BY IB
Nov 22, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 30, 2023 RFCS
REFUSAL PROCESSED BY MPU
Oct 30, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 27, 2023 RFCR
NON-FINAL ACTION WRITTEN
Oct 26, 2023 CNRT
ASSIGNED TO EXAMINER
Oct 17, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Oct 3, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 29, 2023 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Sep 25, 2023 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 21, 2023 REPR